High potential penny stocks

Symbols

6/6/2025 00:44am

Aime

The deep research logic is organized as follows: 

Okay, let's tackle this question about high potential penny stocks. The user is asking for stocks with closing prices under $5, market cap below $300 million, and positive net income growth. They also want the top 10 based on quantitative recommendations. 

First, I need to check the references provided. The first reference has a table with 10 stocks meeting the criteria. Let me go through each one. 

Starting with Theriva Biologics (TOVX.A). Their net income growth is 16.28%, which is good. They're in the biotech sector, which can be high risk but also high reward. The company has some recent positive clinical trial results, which is a plus. Their quantitative score is 0.89, the highest among the list. That's a strong indicator. 

Next is Oil States (OIS) with a 123.61% net income growth. That's impressive. They're in the energy sector, which is cyclical but might benefit from oil price movements. Their market cap is just under $300 million, so they fit the criteria. The quantitative score is 0.82, which is solid. 

Treasure Global (TGL) has a 173.54% growth rate. That's the highest on the list. They're in the tech sector, which is always a hot area. However, their market cap is only $2.96 million, which is very small. High growth but also high risk. The quantitative score is 0.8, which is decent. 

WM Technology (MAPS) with 27.31% growth. They're in the tech sector too, but their market cap is $181 million. The quantitative score is 0.78. Not as high as the others but still in the top half. 

Cardio Diagnostics (CDIO) has 60.73% growth. They're in the healthcare sector, which is stable. Their quantitative score is 0.76. The market cap is $6.8 million, which is quite small. 

SRx Health (SRXH.A) with 65.94% growth. They're in the healthcare sector as well. The quantitative score is 0.61, which is lower. Market cap is $1.86 million. 

Viomi Technology (VIOT) has 149.96% growth. They're in the tech sector, which is good. Market cap is $87.31 million. The quantitative score is 0.58. 

Greenlane Holdings (GNLN) with 13.89% growth. Their market cap is $4.42 million. The quantitative score is 0.57. 

Solidion Technology (STI) has 128.26% growth. They're in the tech sector, specifically advanced materials. Market cap is $9.45 million. The quantitative score is 0.56. 

Lastly, cbdMD (YCBD.A) with 84.03% growth. They're in the healthcare sector, specifically cannabis. Market cap is $8.82 million. The quantitative score is 0.56. 

Now, considering the user's profile, they didn't provide any specific preferences, so I need to focus on the data given. The top 10 are already sorted by quantitative recommendation, so the order is based on that. 

I should highlight the top 3 as the highest potential. Theriva Biologics leads with the highest quantitative score and recent positive clinical data. Oil States follows with high growth and a solid score. Treasure Global is third with the highest growth rate but a smaller market cap. 

For each stock, I need to provide a brief analysis, mentioning their sector, key metrics, and recent news or developments. Also, include the quantitative score and why it's significant. 

Make sure to format the answer with clear sections, tables, and use the required citations. Also, include the visualization for the query mentioned in reference 1. 

I should also mention the risks involved, especially for penny stocks, like liquidity issues and market volatility. 

Finally, structure the answer with a conclusion, detailed analysis, and a table summarizing the top 10. Use emojis to make it engaging as per the format requirements.

🌟 Conclusion

Based on the criteria of closing price < $5, market cap < $300M, net income YoY growth > 10%, and quantitative recommendation score, the top 10 high-potential penny stocks are identified. Theriva Biologics (TOVX.A) leads with the highest quantitative score (0.89) and recent clinical trial success, followed by Oil States (OIS) with a 123.61% net income growth and Treasure Global (TGL) with the highest growth rate (173.54%). These stocks offer high upside potential but come with significant risks due to their small market caps and speculative nature.

📊 Top 10 High-Potential Penny Stocks

Rank	Stock Code	Stock Name	Closing Price	Market Cap	Net Income YoY Growth	Quantitative Score	Key Highlights
1	TOVX.A	Theriva Biologics	$0.47	$4.43M	16.28%	0.89	Biotech, Phase 2b trial success, FDA Fast Track designation ¹²
2	OIS	Oil States	$4.48	$291.4M	123.61%	0.82	Energy, innovation leader, 7 OTC Spotlight awards ¹⁴
3	TGL	Treasure Global	$1.62	$2.96M	173.54%	0.80	Tech, high growth, debt-to-equity ratio < 0.2% ¹⁶
4	MAPS	WM Technology	$1.08	$181.39M	27.31%	0.78	Tech, institutional ownership, short interest updates ¹⁸
5	CDIO	Cardio Diagnostics	$4.52	$6.8M	60.73%	0.76	Healthcare, AI-driven diagnostics, Nasdaq compliance ¹¹⁰
6	SRXH.A	SRx Health	$0.65	$1.86M	65.94%	0.61	Healthcare, PBM partnerships, regulatory updates ¹¹²
7	VIOT	Viomi Technology	$1.45	$87.31M	149.96%	0.58	Tech, smart home devices, China market focus ¹¹³
8	GNLN	Greenlane Holdings	$0.01	$4.42M	13.89%	0.57	Cannabis, distribution partnerships, regulatory compliance ¹¹⁵
9	STI	Solidion Technology	$3.51	$9.45M	128.26%	0.56	Tech, advanced battery tech, solid-state battery patents ¹¹⁷
10	YCBD.A	cbdMD	$0.98	$8.82M	84.03%	0.56	Healthcare, cannabis, revenue growth, NYSE compliance ¹¹⁸

📊 Analysis of Top 3 Picks

1. Theriva Biologics (TOVX.A)

Why? High quantitative score (0.89), recent Phase 2b trial success for VCN-01 in pancreatic cancer, and FDA Fast Track designation ²³.
Risks: High R&D costs ($12M in 2024), cash runway only until Q3 2025 ².
Upside: Potential Phase 3 trial approval and partnerships for SYN-004 ²³.

2. Oil States (OIS)

Why? 123.61% net income growth, innovation leader in energy tech with 7 OTC awards ⁴⁵.
Risks: Small-cap volatility, competition in oilfield services ⁴.
Upside: Strategic partnerships, expansion into floating wind platforms ⁵¹⁹.

3. Treasure Global (TGL)

Why? Highest net income growth (173.54%), debt-to-equity ratio < 0.2% ⁶⁷.
Risks: Tiny market cap ($2.96M), liquidity concerns ¹.
Upside: Expansion in smart home devices, potential acquisitions ⁶.

📊 Key Takeaways

Focus on Biotech & Tech: Theriva Biologics and Treasure Global show the highest growth potential.
Watch Liquidity Risks: Stocks like Greenlane (GNLN) and cbdMD (YCBD.A) have ultra-low market caps.
Diversify Sectors: Mix of healthcare (Theriva, Cardio Diagnostics), energy (Oil States), and tech (Treasure Global, Viomi) for balanced exposure.

closing price < $5; market capitalization < $300 million; net income yoy growth rate > 10%; closing price > 5-day moving average; 5-day moving average > 10-day moving average; top 10 sorted by quantitative recommendation score(10)

Last Price($)	Last Change%	Closing Price($)	Market Cap($)	Net Income Yoy Growth%	ma52025.06.05	ma102025.06.05	Quantitative Recommendation Score
0.47	2.84%	0.471	4.43M	16.28	0.47	0.46	0.89
4.48	0.22%	4.48	291.40M	123.61	4.45	4.43	0.82
1.62	9.46%	1.62	2.96M	173.54	1.49	1.45	0.80
1.08	2.86%	1.08	181.39M	27.31	1.05	1.04	0.78
4.52	-9.42%	4.52	6.80M	60.73	4.43	4.31	0.76
0.65	-3.28%	0.648	1.86M	65.94	0.62	0.60	0.61
1.45	4.32%	1.45	87.31M	149.96	1.40	1.37	0.58
0.01	-4.11%	0.007	4.42M	13.89	0.01	0.01	0.57
3.51	-6.15%	3.51	9.45M	128.26	3.47	3.41	0.56
0.98	1.51%	0.98	8.82M	84.03	0.96	0.96	0.56

Ticker
TOVXTheriva Biologics
OISOil States
TGLTreasure Global
MAPSWM Technology
CDIOCardio Diagnostics
SRXHSRx Health
VIOTViomi Technology
GNLNGreenlane Holdings
STISolidion Technology
YCBDcbdMD

View 10 results more

Source:

1. Closing Price < $5; Market Capitalization < $300 million; Net Income YoY Growth Rate > 10%; Closing Price > 5-Day Moving Average; 5-Day Moving Average > 10-Day Moving Average; Top 10 Sorted by Quantitative Recommendation Score